The interaction between bovine lipoprotein lipase (bLPL) and human a2-macroglobulin (a2M) was studied by use of nondenaturing PAGE and gel-permeation, Zn2+-Sepharose and heparin-Sepharose chromatography. It was demonstrated that bLPL in vitro binds non-covalently to native a2M, but not to the receptor-recognized form produced by treatment of a2M with chymotrypsin or methylamine. A small amount of bLPL was bound covalently to a2M by disulphide interchange, when incubated together with chymotrypsin or methylamine. Whereas
INTRODUCTION
Human a2-macroglobulin (a2M) is a large plasma glycoprotein (720 kDa). The protein consists of four identical subunits covalently held together as dimers and stabilized as tetramers by non-covalent forces [1, 2] . a2M has three functional sites, i.e. a proteinase-sensitive region often denoted as the 'bait-region', an internal thiol ester, which is involved in covalent binding of proteinases on their inactivation, and a receptor-recognition site, which is exposed after bait-region cleavage [3] . a2M is a unique proteinase inhibitor able to inhibit proteinases from all four major classes of proteinases [4] . After proteolytic cleavage of the bait region, conformational changes cause cleavage of the thiol ester, and the proteinase can be covalently bound to a2M via an activated y-glutamyl residue [5] . It has been demonstrated in vitro that non-proteolytic proteins, e.g. insulin, present during the proteolytic activation of a2M, can become covalently bound to a2M [6] . Recent investigations have demonstrated that a2M can bind a number of growth factors and cytokines such as nerve growth factor [7] , platelet-derived growth factor [8] , interleukin lI [9] , interleukin 6 [10] and transforming growth factor a [ 1 1,12] . The binding of these proteins to a2M has been suggested to be non-covalent or covalent by disulphide interchange.
The a2M-proteinase complex is specifically cleared from the circulation by receptor-mediated endocytosis [13, 14] . Much interest has been focused on the a2M receptor since it was demonstrated that this receptor is identical with the low-densitylipoprotein (LDL) receptor-related protein [15, 16] . Besides a2M-proteinase complexes, the receptor can bind apolipoprotein E-containing lipoproteins [17, 18] , and this binding is enhanced by lipoprotein lipase (LPL) [19] , which is shown to bind to the receptor as well [20] . LPL (EC 3.1.1.34) is a 110 kDa homodimeric glycoprotein which interacts with lipids, heparin and apoprotein CII [21] . It is a key enzyme in the catabolism of triacylglycerol-rich lipoproteins, i.e. chylomicrons and very-low-density lipoproteins (VLDL) [22] . The enzyme is only active in its homodimeric form a2M in complex with bLPL still bound to Zn2+-Sepharose, bLPL lost the ability to bind to heparin-Sepharose. Preincubation of bLPL with heparin prevented complex-formation with a2M, suggesting that a2M interacts with the heparin-binding domain of bLPL. Experiments in which 1251-bLPL was incubated with human plasma at 20°C demonstrated an 11-17 % binding of the labelled lipase to a2M, indicating that this interaction may be of physiological significance.
[23] and the presence of apoprotein CII is required for maximal activity [24] . After synthesis by parenchymal cells, LPL is transported to the luminal surface of the capillary endothelium, where it is anchored to membrane-associated heparan sulphate proteoglycans [21, 22] . A low amount of LPL is found in circulating blood [25] [26] [27] [28] and it was recently shown that this LPL is bound to lipoproteins [29] . The plasma concentration of LPL is kept low as the result of avid uptake and degradation by the liver [30] .
During studies of the binding of LPL to lipoproteins by incubation of bovine 125I-labelled LPL (125I-bLPL) with plasma followed by non-denaturing electrophoresis for separation of lipoprotein particles [31] , we observed a radiolabelled band with a Stokes' diameter similar to that of a2M. The purpose of the present study was to analyse the putative binding of 121-bLPL to ox2M.
MATERIALS AND METHODS
Proteins and their derivatives a2M was purified from human plasma as described [14] and stored in 0.1 M sodium phosphate, pH 8.0, at -20 'C. Radiolabelling with 1251 (Amersham) was performed using lodobeads (Pierce). Free iodine was removed by passing the mixtures through a PD-10 column (Pharmacia) equilibrated with PBS, pH 7.4. The specific radioactivity of a2M was 100 c.p.m./ng. a2M was treated for 1 h at room temperature with 0.13 M methylamine with or without 1.5 mM iodoacetamide to produce the 'fast' form derivative of a2M. A twofold molar excess of a-chymotrypsin (EC 3.4.21.1) to a2M was used to produce an a2M-proteinase complex, with or without the presence of 1.5 mM iodoacetamide, for 3 min, and the proteinase activity was terminated by adding 1.2 mM phenylmethanesulphonyl fluoride (PMSF) for 5 min. lodoacetamide and PMSF were removed by dialysis in PBS, pH 7.4, at room temperature for 1 h. bLPL was purified and iodinated as previously described [32] . The NaCl, 20 % (v/v) glycerol, 2 mg/ml BSA, pH 7.4]; the specific radioactivity was 7500 c.p.m./ng.
;2Mand LPL-binding assays '251-bLPL (45 ng ) was incubated at a final concentration of 10 nM with 1.44 #M (10 ,ul) native a2M or derivatives of a2M in 0.1 M sodium phosphate, pH 8.0, for 1 h at 4°C for nondenaturing PAGE assays. For gel-permeation chromatography 2 mg of native cx2M and 750 ng of bLPL were incubated under the same conditions as above before application to the Superose 6 HR column. To assess the effect of heparin on the binding, parallel experiments were carried out with bLPL preincubated with heparin: iodinated or unlabelled bLPL was diluted and incubated with an equal volume of heparin (Fraxiparin, Sanofi Pharma SA; calcium heparinate, average molecular mass Incubation of 1251-bLPL with human plasma Blood was obtained from five non-fasted volunteers and collected in tubes containing EDTA at a final concentration of 2.7 mM. A portion of plasma was used to measure cholesterol, acylglycerol, high-density lipoprotein (HDL) cholesterol and ac2M concentrations. Plasma cholesterol, triacylglycerol and HDL cholesterol were measured by standard enzymic methods [33] . a2M was measured using a turbidimetric kit following the manufacturer's instructions (The Binding Site). The values are shown in Table 1 . Plasma (400 u1l) was incubated with 100 1ul (150 ng) of 1251-bLPL for 1 h at 20 'C; then 5,l of the mixture was diluted with sample buffer for the non-denaturing gradient gel electrophoresis, and, to visualize lipoproteins, the gel was stained with Oil Red 0 [34] . The rest of the mixture was diluted 1: 1 with PBS, pH 7.4, and loaded on the Zn2+-Sepharose column in order to isolate the a2M-_25I-bLPL complex. Incubations were performed at either 4 or 20 'C for 1 h. These temperatures, rather than 37°C, were chosen in order to reduce hydrolysis of plasma lipoproteins by the lipase.
PAGE and autoradiography
Non-denaturing (50% gels) and SDS/PAGE (7.50% gels) was performed as described by Laemmli [35] in a Mini Protean System II (Bio-Rad). Non-denaturing electrophoresis in gradient gels (4-30 %, Pharmacia) was performed in a buffer of Tris/borate/EDTA by the method of Krauss and Burke [34] . Gels to be autoradiographed were exposed at -70°C to X-ray film using intensifying screens.
Gel-permeation chromatography
A Superose 6 HR 10/30 column installed in an h.p.l.c. system (LKB-Pharmacia) at 10°C was equilibrated with PBS, pH 7.4, and run at a flow rate of 0.3 ml/min. Fractions of 0.3 ml were collected. The column was calibrated with a high-molecularmass calibration kit (Sigma), and the void volume, determined by Blue Dextran elution, was at fraction 20. 1251-bLPL run together with 130 ,tg of unlabelled bLPL eluted with a peak of both activity and radioactivity in fraction 71. the gel-permeation chromatography or the plasma incubated with 125I-bLPL) had been loaded, the column was washed with 0.1 M sodium phosphate/0.8 M NaCl, pH 6.5, until the eluted radioactivity was as low as background (wash I). Then the column was washed with 0.02 M sodium phosphate/0. 15 M NaCl, pH 6.0 (wash II). Elution of the a2M (+ 1251-bLPL) was performed with 0.01 M sodium acetate/O.15 M NaCl, pH 5.0 (peak) and the same buffer was used to wash the column after the peak was eluted until radioactivity was as low as background (non-peak). Further elution was then carried out by adding EDTA to a concentration of 20 mM to the sodium acetate buffer (wash III). The Zn2+-chelate chromatography was performed at 4°C and at a flow rate of 1 ml/min. The procedure was as described for purification of a2M [14] . A heparin-Sepharose (2 ml of gel) column was used to bind LPL specifically. A linear gradient (30 ml) from 0 to 1.5 M NaCl in 10 Unlabelled a2M and LPL were detected by sandwich e.l.i.s.a. In both cases the microtitre plate was coated with a polyclonal antibody. A rabbit anti-a2M IgG (DAKO) was used to capture a2M. For LPL, a chicken IgG against bLPL was used [36] , which was purified by adsorption to immobilized bLPL (LPL-Sepharose) and eluted with 0.2 M glycine, pH 2.7. After incubation with the polyclonal antibodies (10 lg/ml in PBS, pH 7.4; 100 4al/well) for 4 h at 37°C, the plates were washed with PBS, pH 7.4. Then 100l1, from each chromatographic fraction was incubated for 12 h at 4 'C. 
Affinity chromatography

RESULTS AND DISCUSSION
In earlier studies when radiolabelled bLPL was incubated with plasma and then subjected to non-denaturing electrophoresis [31] , we observed a labelled band corresponding to a plasma protein with a Stokes' diameter around 15 nm. This could correspond to a2M. Therefore purified human c2M was examined by non-denaturing electrophoresis under the same conditions as the plasma samples. a2M appeared at a similar position to that of the radiolabelled band. In vitro experiments were therefore performed to study the binding of LPL to a2M. Figure 1 shows the in vitro binding of purified 125I-bLPL to purified a2M. Figure  1(a) shows the mobility in a polyacrylamide gel of native, as well as different derivatives of, a2M after incubation with LPL. As demonstrated previously [37] , native a2M (lane 1) has a 'slow' mobility according to the open 'trap' structure of the molecule. On treatment with methylamine, the 'trap' is closed and the mobility becomes 'fast' (lane 2). Treatment of x2M with chymotrypsin also produces 'fast' mobility, but because of the 'trapping' and binding of chymotrypsin, the closure of the 'trap' is less pronounced than in methylamine-treated a2M [38] (lane 4). In lane 6 both the 'slow' and 'fast' forms are present, as only about half of the a2M is converted into the 'fast' form by the addition of half the molar amount of chymotrypsin compared with a2M. Incubation of ac2M with iodoacetamide has no effect on the mobility. This treatment blocks the thiol groups liberated from the thiol esters when x2M is treated with methylamine or chymotrypsin. Figure l(b) shows the autoradiograph of the gel in Figure 1(a) . The band at the top of the gel is free LPL which is not expected to enter because of a higher pl value than the pH of the buffer system used in the PAGE [39] . I251-bLPL binds to native a2M (lane 1), but not to any of the 'fast' forms produced by methylamine or chymotrypsin (lanes 2 and 4) . If LPL is present when native a2M is incubated with methylamine or chymotrypsin, binding to a2M occurs (lanes 3 and 5 respectively). As LPL does not bind to the 'fast' form of a2M, the binding must be due to either non-covalent 'trapping' or covalent binding by the y-glutamyl residue of the thiol group of the activated thiol ester. LPL binds to a2M during incubation with methylamine in the presence of iodoacetamide (lane 7). This indicates that LPL is non-covalently 'trapped' in x2M during the 'slow' to 'fast' transformation. The samples incubated with iodoacetamide demonstrate weaker radioactive bands than the samples without iodoacetamide (lanes 5 and 8 for chymotrypsin incubation and lanes 3 and 7 for methylamine incubations respectively). This indicates that, in addition to 'trapping', some LPL is bound covalently to a2M at the thiol group. This was supported by SDS/PAGE of the same samples, which demonstrated no covalent binding of LPL to a2M, except when LPL was incubated together with methylamine or chymotrypsin (not shown). The radiolabelled complexes disappeared when SDS/PAGE was performed on reduced samples.
Binding of LPL to a2M was also studied using gel-permeation chromatography. 1251-bLPL and unlabelled LPL were incubated with native a2M and the mixture was applied to the column. 1251-bLPL and a2M were incubated and subjected to gel-permeation chromatography as described In the Materials and methods section. The peak fractions were pooled and then loaded on a heparin-Sepharose column (for details see the Materials and methods section). After the sample (approx. 4 ml) was loaded, 10 ml (fractions -10 to 0, in the diagrams) of 10 mM Tris/HCI, pH 7.4, buffer was passed through to wash out the unbound material followed by elution with a gradient of NaCI in 10 mM Tris/HCI. For each sample, 15 ml of 0 M NaCI/l 0 mM Tris buffer and 15 ml of 1.5 M NaCI/lO mM Tris buffer at a flow rate of 1 ml/min were used. Fractions of 1 ml were collected. Radioactivity was measured in each fraction when labelled proteins were used, and the unlabelled 'X2M was detected by e.l.i.s.a. as described in the Materials and methods section. In (a): 0, 1251-bLPL; 0, [NaCI]. In Recoveries of radioactivity from the column were 60-70%. Elution of both a2M and LPL was detected by sandwich e.l.i.s.a.; the results are shown in Figure 2 . The profile for a2M when in complex with the lipase was essentially the same as for the protein alone (Figures 2a and 2c ). LPL was eluted in fraction 71 (Figure 2b) , somewhat retarded in comparison with BSA which was eluted in fraction 53. This retardation of LPL could be due to its interaction with the gel matrix. However, when preincubated with a2M, LPL was eluted in fraction 38 ( Figure  2c ). When LPL was preincubated with heparin, only a fraction of the LPL was co-eluted with a2M ( Figure 2d ). This suggests that heparin partly prevents complex-formation between LPL and a2M. Furthermore, specific binding of LPL to a2M was supported by the fact that LPL was not co-eluted with other proteins such as rabbit IgG or albumin (not shown).
To study further the interaction between a2M and LPL, samples from the peak fractions of gel-permeation chroma-tography were applied to a heparin-Sepharose column and to a chelating Zn2+-Sepharose 4B column, which are able to bind LPL [32] and a2M [14] respectively. As shown in Table 2 , free 'l25-bLPL did not bind to the Zn2+-Sepharose. When the putative LPL-a2M complex was applied, more than 60 % of the LPL radioactivity was bound and 40 % of this was eluted together with a2M. These results further support the hypothesis that the two proteins interact with each other. As seen in Figure  3 (a), 1251I-bLPL bound to the heparin-Sepharose column, but 125I-a2M did not (Figure 3b ). LPL did not bind to heparin-Sepharose when it was bound to a2M (Figure 3c ). The lack of binding of the complex (LPL-a2M) to heparin-Sepharose and the prevention of the interaction by preincubation of LPL with heparin, as described above, demonstrates that either the lipase was 'trapped' inside a2M or that the heparin-binding domain of LPL was masked by binding to a2M. In the gel-filtered complex of LPL and a2M, the lipase was still catalytically active (as demonstrated by activity measurements according to [40] ) and LPL in the complex was still recognized by the antibodies in the sandwich e.l.i.s.a. This suggests an LPL-a2M complex, in which at least parts of LPL were not hidden.
To extend the study to more physiological conditions, 1251_ bLPL was added to human plasma. The concentration of LPL in human plasma is low (69.8 + 6.6 ng/ml) and the enzyme is present mainly in its monomeric inactive form [31] , assuming that its molecular mass is 55 kDa, it corresponds to 1.3 nM.
However, the concentration of a2M is about 2.8 ,M [41] . Thus, in plasma the ratio of a2M to LPL (mol/mol) is about 2000. Consequently, there is a2M available for exogenously added LPL. Therefore experiments were carried out in which plasma from five subjects was incubated with labelled '251-bLPL. The mixture of plasma and labelled bLPL was examined by PAGE and the a2M-'251-bLPL complexes were isolated using the Zn2+-Sepharose column. Figure 4 (a) represents the lipoprotein distribution for the five subjects studied in a 4 30% nondenaturing polyacrylamide gel. The autoradiogram, shown in Figure 4 (b), was scanned to quantify the radioactivity in each band and the results demonstrated that about 7-10% of the labelled lipase co-migrated with a2M, and the rest was associated with lipoproteins (50-58 % with VLDL-LDL and 35 40 % with large HDL).
The results from Zn2+-Sepharose chromatography are shown in Table 3 . Incubation at 4°C showed that of the total LPL added to plasma about 2 % was eluted with a2M. However, when incubation was carried out with the same sample but at 20°C, up to I 1-17 % of the loaded lipase was eluted together with a2M. To confirm that 1251-bLPL was actually bond to a2M, eluted 
